Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples.

Schmidt AF, Rovers MM, Klungel OH, Hoes AW, Knol MJ, Nielen M, de Boer A, Groenwold RH.

J Clin Epidemiol. 2013 Jun;66(6):599-607. doi: 10.1016/j.jclinepi.2012.08.008. Epub 2013 Mar 16. Review.

2.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

3.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

4.

A systematic review of analytical methods used to study subgroups in (individual patient data) meta-analyses.

Koopman L, van der Heijden GJ, Glasziou PP, Grobbee DE, Rovers MM.

J Clin Epidemiol. 2007 Oct;60(10):1002-9. Epub 2007 Aug 1. Review.

PMID:
17884593
5.

Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes.

Cheung BM, Lauder IJ, Lau CP, Kumana CR.

Br J Clin Pharmacol. 2004 May;57(5):640-51.

6.

Statin use and risk of breast cancer: a meta-analysis of observational studies.

Undela K, Srikanth V, Bansal D.

Breast Cancer Res Treat. 2012 Aug;135(1):261-9. doi: 10.1007/s10549-012-2154-x. Epub 2012 Jul 18.

PMID:
22806241
7.

Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies.

Liu T, Li L, Korantzopoulos P, Liu E, Li G.

Int J Cardiol. 2008 May 23;126(2):160-70. Epub 2007 Nov 26. Review.

PMID:
18031847
8.

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.

Kulik A, Ruel M.

Expert Opin Drug Saf. 2009 Sep;8(5):559-71. doi: 10.1517/14740330903188413. Review.

PMID:
19673591
9.

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

Bonovas S, Filioussi K, Tsavaris N, Sitaras NM.

J Clin Oncol. 2005 Dec 1;23(34):8606-12. Epub 2005 Oct 31.

PMID:
16260694
10.

Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.

Collard CD, Body SC, Shernan SK, Wang S, Mangano DT; Multicenter Study of Perioperative Ischemia (MCSPI) Research Group, Inc; Ischemia Research and Education Foundation (IREF) Investigators.

J Thorac Cardiovasc Surg. 2006 Aug;132(2):392-400.

11.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
12.

Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery.

Mariscalco G, Lorusso R, Klersy C, Ferrarese S, Tozzi M, Vanoli D, Domenico BV, Sala A.

Ann Thorac Surg. 2007 Oct;84(4):1158-64.

PMID:
17888963
13.

Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.

Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA.

Ann Intern Med. 2007 Nov 20;147(10):703-16. Epub 2007 Oct 15. Review.

PMID:
17938385
14.

Evidence of pre-procedural statin therapy a meta-analysis of randomized trials.

Winchester DE, Wen X, Xie L, Bavry AA.

J Am Coll Cardiol. 2010 Sep 28;56(14):1099-109. doi: 10.1016/j.jacc.2010.04.023. Epub 2010 Aug 31. Review.

15.

Drug-eluting stents versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of early outcomes from randomized and nonrandomized studies.

Cao C, Manganas C, Bannon P, Vallely M, Yan TD.

J Thorac Cardiovasc Surg. 2013 Mar;145(3):738-47. doi: 10.1016/j.jtcvs.2012.02.004. Epub 2012 Mar 9.

16.

Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.

Thielmann M, Neuhäuser M, Marr A, Jaeger BR, Wendt D, Schuetze B, Kamler M, Massoudy P, Erbel R, Jakob H.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1143-9.

17.

Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.

Capodanno D, Stone GW, Morice MC, Bass TA, Tamburino C.

J Am Coll Cardiol. 2011 Sep 27;58(14):1426-32. doi: 10.1016/j.jacc.2011.07.005.

18.
19.

Using routine data to complement and enhance the results of randomised controlled trials.

Lewsey JD, Leyland AH, Murray GD, Boddy FA.

Health Technol Assess. 2000;4(22):1-55.

20.

Meta-analysis of three randomized trials and nine observational studies comparing drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary artery disease.

Jang JS, Choi KN, Jin HY, Seo JS, Yang TH, Kim DK, Kim DS, Urm SH, Chun JH, Kang SJ, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.

Am J Cardiol. 2012 Nov 15;110(10):1411-8. doi: 10.1016/j.amjcard.2012.06.051. Epub 2012 Aug 8. Review.

PMID:
22877423

Supplemental Content

Support Center